Heart Test Laboratories, Inc. (HeartSciences) has filed its definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) on September 18, 2024, for its upcoming Annual Meeting of Shareholders scheduled for November 7, 2024. The meeting will be held virtually via a live audio webcast. Shareholders will vote on the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025, and on the approval of an adjournment of the Annual Meeting if necessary to solicit additional proxies. The company did not hold a 2023 Annual Meeting of Shareholders, and as such, is soliciting approval for both its Class I and Class II director nominees collectively. The sole Class III director nominee's term expires at the 2025 Annual Meeting, and therefore, no approval for this position is sought at the current meeting. Shareholders as of the record date, September 16, 2024, are entitled to vote, and the company has provided various methods for shareholders to submit their proxies.

Heart Test Laboratories, Inc. (HeartSciences) has filed its definitive proxy statement with the U.S. Securities and Exchange Commission (SEC) on September 18, 2024, for its upcoming Annual Meeting of Shareholders scheduled for November 7, 2024. The meeting will be held virtually via a live audio webcast. Shareholders will vote on the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025, and on the approval of an adjournment of the Annual Meeting if necessary to solicit additional proxies. The company did not hold a 2023 Annual Meeting of Shareholders, and as such, is soliciting approval for both its Class I and Class II director nominees collectively. The sole Class III director nominee's term expires at the 2025 Annual Meeting, and therefore, no approval for this position is sought at the current meeting. Shareholders as of the record date, September 16, 2024, are entitled to vote, and the company has provided various methods for shareholders to submit their proxies.